No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database

Published:2014-01 Issue:1 Volume:17 Page:19214
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:Journal of the International AIDS Society

Author:

Napoli Andrew A,Wood Jennifer J,Coumbis John J,Soitkar Amit M,Seekins Daniel W,Tilson Hugh H

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference23 articles.

1. Bristol-Myers Squibb Sustiva (efavirenz) Package Insert 2014 http://packageinserts.bms.com/pi/pi_sustiva.pdf

2. Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals;Clifford;Ann Intern Med.,2005

3. Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients;Hawkins;HIV Clin Trials,2005

4. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz;Lochet;HIV Med,2003

5. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data;Mollan;Ann Intern Med.,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system;Frontiers in Pharmacology;2024-07-10

2. Identification of Signal of Clindamycin Associated Renal Failure Acute: A Disproportionality Analysis;Current Drug Safety;2024-02

3. A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?;Frontiers in Pharmacology;2023-10-26

4. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

5. Updated Insights on Cardiac and Vascular Risks of Proton Pump Inhibitors: A Real-World Pharmacovigilance Study;Frontiers in Cardiovascular Medicine;2022-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3